Insmed, Inc. (INSM)
164.91
+3.91
(+2.43%)
USD |
NASDAQ |
Feb 20, 16:00
164.92
+0.01
(+0.01%)
After-Hours: 20:00
Insmed Profit Margin (Quarterly) : -124.5% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Biogen, Inc. | -2.24% |
| Mirum Pharmaceuticals, Inc. | 2.18% |
| Madrigal Pharmaceuticals, Inc. | -18.24% |
| CorMedix, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -192.4% |
| Return on Assets | -58.39% |
| Return on Invested Capital | -77.98% |
| Gross Profit Margin (Quarterly) | 82.51% |
| Operating Margin (Quarterly) | -94.64% |
| Return on Net Operating Assets | -249.3% |